September 2026

Regulatory Approvals

FDA Approves Levacetylleucine for Ataxia-Telangiectasia

Sep 18, 2026

FDA Approves Levacetylleucine for Ataxia-Telangiectasia NeurologyLive

Credit Ratings

Provinces hang on to ‘AA’ ratings: Fitch

Sep 18, 2026

Provinces hang on to ‘AA’ ratings: Fitch Investment Executive

Credit Ratings

Fitch Affirms Morocco at BB+ With Stable Outlook Despite Wider 2026 Deficits

Sep 18, 2026

Fitch Affirms Morocco at BB+ With Stable Outlook Despite Wider 2026 Deficits Morocco World News

Credit Ratings

Fitch affirms MetLife ratings with stable outlook amid strong earnings

Sep 18, 2026

Fitch affirms MetLife ratings with stable outlook amid strong earnings beinsure.com

Credit Ratings

Fitch Ratings Initiates Coverage of Adecoagro with a BB Corporate Credit Rating and Stable Outlook

Sep 18, 2026

Fitch Ratings Initiates Coverage of Adecoagro with a BB Corporate Credit Rating and Stable Outlook TradingView

Regulatory Approvals

Dostarlimab Receives FDA Approval for MSI-H/dMMR Locally Advanced Rectal Cancer

Regulatory Approvals

FDA Approves Ryzumvi Eye Drops for Presbyopia

Regulatory Approvals

Haemonetics says FDA clears vascular closure device

Regulatory Approvals

FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery